Background illustration for clinical trials search

Paid Clinical Trials Albuquerque

Discover 303 paid clinical trials in Albuquerque, New Mexico. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

for
Endometrial Cancer, Gastric Cancer,
Location: Albuquerque NM, Los Angeles CA, Houston TX,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT05489211

Phase2, Recruiting

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

for
Breast Cancer
Location: Albuquerque NM, El Paso TX, Aurora CO, Dallas TX,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06103864

Phase3, Recruiting

American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)

for
Diabetes Mellitus, Chronic Kidney Diseases, Heart Diseases,
Location: Albuquerque NM, Black Rock NM
Sponsor: University of New Mexico

Sex: All

Age: 21 - 70+

Code: NCT04185844

Recruiting

Suicide in Urban Natives: Detection and Networks to Combat Events

for
Suicide Prevention
Location: Albuquerque NM
Sponsor: University of Colorado, Denver

Sex: All

Age: 18 - 34

Code: NCT03136094

Recruiting

WEAVE NM: Heart Health and Nutrition for Life

for
Hypertension
Location: Albuquerque NM
Sponsor: University of New Mexico

Sex: All

Age: 18 - 70+

Code: NCT07074145

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration

for
Neovascular Age-related Macular Degeneration, nAMD
Location: Albuquerque NM, Colorado Springs CO, Lakewood CO,
Sponsor: Amgen

Sex: All

Age: 50+

Code: NCT07614776

Phase3, Recruiting

A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio

for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Albuquerque NM, Mesa AZ, Scottsdale AZ, Gilbert AZ,
Sponsor: Apellis Pharmaceuticals, Inc.

Sex: All

Age: 60+

Code: NCT07215390

Phase2, Recruiting

Telescope Exchange Study

for
Age-related Macular Degeneration
Location: Albuquerque NM, Phoenix AZ, Fort Worth TX,
Sponsor: VisionCare, Inc.

Sex: All

Age: 65+

Code: NCT03011554

Recruiting

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

for
Age-related Macular Degeneration (AMD), Geographic Atrophy (GA)
Location: Albuquerque NM, Durango CO, Colorado Springs CO,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 50 - 70+

Code: NCT06541704

Phase3, Recruiting

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Albuquerque NM, Rio Rancho NM, Tucson AZ, Phoenix AZ,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05987241

Phase2, Phase3, Recruiting

A Clinical Study of YL205 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Albuquerque NM, Las Vegas NV, Oklahoma City OK,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

Sex: All

Age: 18+

Code: NCT06459973

Phase1, Phase2, Recruiting

A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis

for
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Location: Albuquerque NM, Scottsdale AZ, Aurora CO, Surprise AZ,
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT06072482

Recruiting

The Effect of Hand Exercises on Upper Limb Volume, Quality of Life, and Hand Function in Breast Cancer Survivors

for
Breast Cancer Lymphedema
Location: Albuquerque NM, Rio Rancho NM, Santa Fe NM
Sponsor: Texas Woman's University

Sex: Female

Age: 18+

Code: NCT05983380

Recruiting

BostonGene and Exigent Genomic INsight Study

for
Breast Cancer, Non-small Cell Lung Cancer, Melanoma, Sarcoma
Location: Albuquerque NM, Tulsa OK, Rogers AR, Houston TX,
Sponsor: BostonGene

Sex: All

Age: 18+

Code: NCT06272864

Recruiting

Efficacy Study of Inecalcitol With Decitabine in Acute Myeloid Leukemia Patients Unfit for Standard Chemotherapy

for
Acute Myelogenous Leukemia
Location: Albuquerque NM, Las Vegas NV, San Diego CA, Houston TX,
Sponsor: Hybrigenics Corporation

Sex: All

Age: 65+

Code: NCT02802267

Phase2, Recruiting

A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data

for
Cancer
Location: Albuquerque NM, Houston TX, Monterey CA,
Sponsor: N-Power Medicine

Sex: All

Age: 18 - 70+

Code: NCT06877884

Recruiting

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

for
Breast Cancer
Location: Albuquerque NM, Lubbock TX, Tucson AZ, Scottsdale AZ,
Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06492616

Phase3, Recruiting

Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer

for
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Location: Albuquerque NM, Abilene TX, New Braunfels TX,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT06801834

Phase3, Recruiting

A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

for
Prostate Cancer,
Location: Albuquerque NM, Wichita KS, Dallas TX, Anaheim CA,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: Male

Age: 18+

Code: NCT04729114

Phase1, Recruiting

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

for
Triple-Negative Breast Cancer
Location: Albuquerque NM, Santa Fe NM, Amarillo TX,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06393374

Phase3, Recruiting